Testing conditions for determination of minimum fungicidal concentrations of new and established antifungal agents for Aspergillus spp.: NCCLS Collaborative Study

Journal of Clinical Microbiology

Volumn 40, Issue 9, 2002, Pages 3204-3208

  Espinel Ingroff, A ^a   Fothergill, A ^a   Peter, J ^a   Rinaldi, M G ^a   Walsh, T J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; ITRACONAZOLE; POSACONAZOLE; RAVUCONAZOLE; VORICONAZOLE;

ARTICLE; ASPERGILLUS; DRUG ACTIVITY; DRUG SENSITIVITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REPRODUCIBILITY; ANTIBIOTIC RESISTANCE; CLASSIFICATION; CULTURE MEDIUM; DRUG EFFECT; EVALUATION; HUMAN; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; STANDARD;

ANTIFUNGAL AGENTS; ASPERGILLUS; CULTURE MEDIA; DRUG RESISTANCE, FUNGAL; HUMAN; MICROBIAL SENSITIVITY TESTS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SUPPORT, NON-U.S. GOV'T; HUMANS;

EID: 0036708307     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.40.9.3204-3208.2002     Document Type: Article

References (27)

1. Quality control limits for broth microdilution susceptibility tests of 10 antifungal agents
2. Itraconazole in experimental pulmonary aspergillosis: Comparison with amphotericin B, interaction with cyclosporin A, and correlation between therapeutic response and itraconazole plasma concentrations
3. In vitro efficacy and fungicidal activity of voriconazole against Aspergillus and Fusarium species
4. Therapeutic outcome in invasive aspergillosis
5. Itraconazole resistance in Aspergillus fumigatus
6. Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts
7. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi
8. Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi
9. Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi
10. Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.: NCCLS collaborative study
11. In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: Review of the literature
12. Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: The potential role of bronchoalveolar lavage D-mannitol and galactomannan as markers of infection
13. In vitro activity of a new oral triazole, BMS-207147 (ER-30346)
14. In vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi
15. Lack of correlation of in vitro amphotericin B susceptibility testing with outcome in a murine model of Aspergillus infection
16. In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum
17. Comparative study of susceptibilities of germinated and ungerminated conidia of Aspergillus fumigatus to various antifungal agents
18. Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia
19. In vitro activity of SCH-56592 and comparison with activities of amphotericin B and itraconazole against Aspergillus spp.
20. Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and itraconazole-resistant isolate of Aspergillus fumigatus
21. Antifungal activity and plasma pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: Correlation with galactomannan antigenemia
22. In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole
23. Invasive aspergillosis caused by Aspergillus ustus: Case report and review
24. Trichosporon beigelii, an emerging pathogen to amphotericin B
25. Experimental disseminated trichosporonosis in persistently granulocytopenic rabbits: Implications for pathogenesis, diagnosis, and treatment of an emerging opportunistic infection